SandboxAQ brings its drug discovery models to Claude — no PhD in computing required

Drug discovery is one of the most expensive failures in modern industry. Finding a single viable molecule can take a decade and cost billions, and most candidates still don’t make it. A generation of AI startups has promised to fix that — most have made the problem less painful for researchers, who are already technically sophisticated enough to use the tools.

But SandboxAQ thinks the bottleneck isn’t the models. It’s the interface.